Loading...

Cipher Pharmaceuticals Inc.

CPHRF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$10.93
$0.03(0.32%)

Cipher Pharmaceuticals Inc. (CPHRF) Stock Overview

Explore Cipher Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.6/100

Key Financials

Market Cap279.4M
P/E Ratio23.30
EPS (TTM)$0.46
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$9.10
1 Month$9.14
3 Months$12.52
1 Year Target$17.86

CPHRF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cipher Pharmaceuticals Inc. (CPHRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $17.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.30 and a market capitalization of 279.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.48%
5-Day Change
-9.71%
1-Month Change
1.98%
3-Month Change
-21.78%
6-Month Change
-38.88%
Year-to-Date (YTD) Change
-21.46%
1-Year Change
25.73%
3-Year Change
295.90%
5-Year Change
1475.51%
All-Time (Max) Change
85.13%

Contact Information

https://www.cipherpharma.com
905-602-5840
209 Oak Park Boulevard, Mississauga, ON, L6H 0M2

Company Facts

6 Employees
IPO DateFeb 2, 2006
CountryCA
Actively Trading

Frequently Asked Questions

;